Romosozumab versus placebo, alendronate, and teriparatide for postmenopausal osteoporosis

Climacteric. 2018 Apr;21(2):189-195

Education and follow-up improves osteoporosis treatment following hip fracture

J Bone Joint Surg Am. 2005 Jan;87(1):3-7.

Vitamin K2 is effective for management of osteoporosis in postmenopausal women

Osteoporos Int. 2015 Mar;26(3):1175-86.

Combined parathyroid hormone+alendronate therapy versus PTH monotherpy for osteoporosis

J Invest Surg. 2015 Dec;28(6):309-16

Orthopaedic surgeon led osteoporosis management improves the rate of treatment at 6 month

J Bone Joint Surg Am. 2008 Nov;90(11):2346-53.

Sling exercise therapy improves quality of life in osteoporosis patients

Health Qual Life Outcomes. 2012 Aug 24;10:101. doi: 10.1186/1477-7525-10-101.

Larger BMD gains in osteoporosis patients transitioning to denosumab versus other active controls

Expert Opin Drug Saf. 2018 Apr;17(4):413-428

Strontium ranelate and alfa D3 improve outcomes of postmenopausal osteoporosis

Drugs R D. 2014 Dec;14(4):315-24.

Incidence of falls reduced following balance training in patients with osteoporosis

J Rehabil Med. 2018 Jul 17;50(7):577-581. doi: 10.2340/16501977-2334

Evaluating raloxifene in postmenopausal Japanese women with osteoporosis or osteopenia

Clin Interv Aging. 2014 Nov 5;9:1879-1893.

WCO-IOF: 12-week balance training improves balance and function in women with osteoporosis

Network meta-analysis of anti-osteoporosis therapies for oral glucocorticoid users

Osteoporos Int. 2016 Jun;27(6):1989-98

WCO-IOF 2016: Daily subcutaneous abaloparatide vs teriparatide & placebo for osteoporosis

Teriparatide increases BMD in patients with glucocorticoid-Induced osteoporosis

N Engl J Med. 2007 Nov 15;357(20):2028-39

Resistance training and PEMF in hemophilia patients with osteoporosis

Clin Rehabil. 2014 May;28(5):440-50. doi: 10.1177/0269215513505299. Epub 2013 Nov 18.

Direct referral for DXA scan led to improved diagnosis and treatment of osteoporosis

Osteoporos Int. 2013 Mar;24(3):1089-94. doi: 10.1007/s00198-012-2238-9. Epub 2012 Dec 15

Network meta-analysis of current drug options for the treatment of osteoporosis in men

PLoS One. 2015 May 26;10(5):e0128032

Zoledronic acid increases BMD and prevents fracture risks in women with osteoporosis

J Int Med Res. 2013 Jun;41(3):697-704. doi: 10.1177/0300060513480917. Epub 2013 May 13

Combined & extended alendronate with teriparatide improves BMD in women with osteoporosis

J Bone Miner Res. 2014 Aug;29(8):1777-85

Osteoporosis: Weekly 28.2ug teriparatide reduces vertebral fracture risk

Calcif Tissue Int. 2014 Feb;94(2):170-5. doi: 10.1007/s00223-013-9777-8. Epub 2013 Aug 21